

[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI
[ Fri, Feb 23rd 2024
] - WOPRAI

[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
[ Thu, Feb 22nd 2024
] - WOPRAI
Tobey Sommer Maintained (CCRN) at Hold with Decreased Target to $16 on, Feb 22nd, 2024
Tobey Sommer of Truist Securities, Maintained "Cross Country Healthcare, Inc." (CCRN) at Hold with Decreased Target from $22 to $16 on, Feb 22nd, 2024.
Tobey has made no other calls on CCRN in the last 4 months.
There are 4 other peers that have a rating on CCRN. Out of the 4 peers that are also analyzing CCRN, 3 agree with Tobey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Constantine Davides of "JMP Securities" Initiated at Hold on, Wednesday, December 6th, 2023
- A.J. Rice of "UBS" Initiated at Hold and Held Target at $22 on, Thursday, November 30th, 2023
- Brian Tanquilut of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $21 on, Friday, November 3rd, 2023
This is the rating of the analyst that currently disagrees with Tobey
- Kevin Steinke of "Barrington Research" Maintained at Buy with Decreased Target to $26 on, Wednesday, November 29th, 2023
Contributing Sources